TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 0 | -2 | -5 | -3 | 4 | 99 | 19 |
| P | %wins | 50 | 0 | 50 | 0 | 50 | 100 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/29/16 14:57 | 8/25/16 | JNP | Juniper Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Secor Alicia | MA | DO | P,CEO | P | 29 | 5.75 | 0 | 5 | New | 5 | D | -5 | -48 | -24 | -17 | -25 | -18 | -20 | -5 | 1 | -3 | 2 | -1 | -13 | |
6/23/14 17:52 | 6/19/14 | ZFGN | Zafgen, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Secor Alicia | MA | O | Chief Co | P | 80 | 20.00 | 33 | 4 | New | 4 | I | -1 | -1 | -11 | -5 | 21 | 99 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |